ReGen Biologics, Inc. to Present at Canaccord Adams Musculoskeletal Conference Prior to AAOS Annual Meeting

HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBO) (“ReGen” or the “Company”), an orthopedic products company with a meniscus repair device that recently received FDA clearance, announced it will present at the Canaccord Adams Musculoskeletal Conference on Tuesday, February 24 at the University of Nevada in Las Vegas. Gerald E. Bisbee, Jr., Ph.D., the Company’s Chairman and CEO, will make the presentation at 10:40 a.m. (PST). A copy of the presentation will be available on the Company’s website at www.regenbio.com following the meeting.